Granulocyte-macrophage colony-stimulating factor: present use and future directions.
Shadduck
R K
RK
Western Pennsylvania Cancer Institute, West Penn Hospital, Pittsburgh 15224.
D004341:Drug Evaluation; D005544:Forecasting; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000494:pharmacology / Q000627:therapeutic use*; D006402:Hematologic Diseases / Q000628:therapy; D006410:Hematopoiesis / Q000187:drug effects; D016298:Hematopoietic Cell Growth Factors / Q000494:pharmacology / Q000627:therapeutic use; D006412:Hematopoietic Stem Cells / Q000187:drug effects; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D015470:Leukemia, Myeloid, Acute / Q000473:pathology / Q000628:therapy; D008262:Macrophage Activation / Q000187:drug effects; D009369:Neoplasms / Q000628:therapy; D011994:Recombinant Proteins / Q000494:pharmacology / Q000627:therapeutic use
D016298:Hematopoietic Cell Growth Factors; D007155:Immunologic Factors; D011994:Recombinant Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor